| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53
|
Kalous, Ondrej
|
|
2013
|
141 |
3 |
p. 397-408
|
artikel
|
| 2 |
Analysis of phyllodes tumor recurrence according to the histologic grade
|
Kim, Sewha
|
|
2013
|
141 |
3 |
p. 353-363
|
artikel
|
| 3 |
A phase 2 study of everolimus combined with trastuzumab and paclitaxel in patients with HER2-overexpressing advanced breast cancer that progressed during prior trastuzumab and taxane therapy
|
Hurvitz, Sara A.
|
|
2013
|
141 |
3 |
p. 437-446
|
artikel
|
| 4 |
Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis
|
Rose, April A. N.
|
|
2013
|
141 |
3 |
p. 331-339
|
artikel
|
| 5 |
Clinical characteristics of breast cancer in patients with an NBS1 mutation
|
Huzarski, T.
|
|
2013
|
141 |
3 |
p. 471-476
|
artikel
|
| 6 |
DHA is a more potent inhibitor of breast cancer metastasis to bone and related osteolysis than EPA
|
Rahman, Md Mizanur
|
|
2013
|
141 |
3 |
p. 341-352
|
artikel
|
| 7 |
Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers
|
Lee, Jun Sang
|
|
2013
|
141 |
3 |
p. 477-484
|
artikel
|
| 8 |
Genetic variants in microRNAs and breast cancer risk in African American and European American women
|
Yao, Song
|
|
2013
|
141 |
3 |
p. 447-459
|
artikel
|
| 9 |
Identification of two novel BRCA1-partner genes in the DNA double-strand break repair pathway
|
Guglielmi, Chiara
|
|
2013
|
141 |
3 |
p. 515-522
|
artikel
|
| 10 |
Metastasis tumor-associated protein 2 enhances metastatic behavior and is associated with poor outcomes in estrogen receptor-negative breast cancer
|
Covington, Kyle R.
|
|
2013
|
141 |
3 |
p. 375-384
|
artikel
|
| 11 |
Multivitamin and mineral use and breast cancer mortality in older women with invasive breast cancer in the women’s health initiative
|
Wassertheil-Smoller, S.
|
|
2013
|
141 |
3 |
p. 495-505
|
artikel
|
| 12 |
Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice
|
Ruddy, Kathryn J.
|
|
2013
|
141 |
3 |
p. 421-427
|
artikel
|
| 13 |
Pharmacological treatment of depression in women with breast cancer: a systematic review
|
Andersen, Lærke Toftegård
|
|
2013
|
141 |
3 |
p. 325-330
|
artikel
|
| 14 |
Phase I–II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin–cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinoma
|
Andreopoulou, Eleni
|
|
2013
|
141 |
3 |
p. 429-435
|
artikel
|
| 15 |
Post-surgical highly sensitive C-reactive protein and prognosis in early-stage breast cancer
|
Tibau, Ariadna
|
|
2013
|
141 |
3 |
p. 485-493
|
artikel
|
| 16 |
Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome
|
Lobbezoo, Dorien J. A.
|
|
2013
|
141 |
3 |
p. 507-514
|
artikel
|
| 17 |
Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer
|
Rugo, Hope S.
|
|
2013
|
141 |
3 |
p. 461-470
|
artikel
|
| 18 |
Radiation- and anthracycline-induced cardiac toxicity and the influence of ErbB2 blocking agents
|
Seemann, Ingar
|
|
2013
|
141 |
3 |
p. 385-395
|
artikel
|
| 19 |
The expression of redox proteins in phyllodes tumor
|
Kim, Sewha
|
|
2013
|
141 |
3 |
p. 365-374
|
artikel
|
| 20 |
The molecular diversity of Luminal A breast tumors
|
Ciriello, Giovanni
|
|
2013
|
141 |
3 |
p. 409-420
|
artikel
|
Tijdschrift beschrijving